Quantitation of nanoparticle accumulation in flow using optimized microfluidic chambers

J. Kusunose, M. K J Gagnon, Jai Seo, K. W. Ferrara

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The vascular cell adhesion molecule-1 (VCAM-1) targeting peptide sequence, VHPKQHR, is a promising moiety for targeting atherosclerosis through incorporation into nanoparticles such as dendrimers and liposomes. Purpose: We aim to develop VCAM-1-targeted nanoparticles that effectively accumulate on the endothelium under shear conditions and to develop robust microfluidic chambers able to house sufficient cells for flow cytometric measurements. Methods: Carboxyfluorescein-labeled monomeric VHP-peptide, tetrameric VHP-dendrimers (bisbidentate or radial architecture, with or without N-terminal acetylation) and VHP-peptide liposomes were prepared. Human umbilical vein endothelial cells were treated with nanoparticles under 0 or 2.9 dyne/cm2 shear, and particle binding was quantified. Flow chambers cured at various temperatures, with or without glass backings were fabricated, characterized for deformation and applied in experiments. Results: Although liposomes accumulated with highest efficiency, dendrimers also demonstrated specific binding. N-terminal acetylation significantly reduced dendrimer binding, and despite shorter movement range, bisbidentate dendrimers outperformed radial dendrimers, suggesting multiple epitope presence within its estimated arm-span of 57Å. Under shear, while liposome binding increased 300%, dendrimer binding to cells decreased 65%. Through higher temperature curing and glass backing insertion, polydimethylsiloxane flow chambers maintaining rectangular cross-section with aspect-ratio as low as 1:111 were achieved. Conclusion: Optimized dendrimers and liposomal nanocarriers specifically accumulated onto cells within microfluidic chambers.

Original languageEnglish (US)
Pages (from-to)48-56
Number of pages9
JournalJournal of Drug Targeting
Volume22
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Dendrimers
Microfluidics
Nanoparticles
Liposomes
Vascular Cell Adhesion Molecule-1
Acetylation
Peptides
Glass
Temperature
Human Umbilical Vein Endothelial Cells
Endothelium
Epitopes
Atherosclerosis

Keywords

  • Atherosclerosis
  • Dendrimers
  • in vitro model
  • Liposomes
  • Peptide
  • Targeted drug delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Quantitation of nanoparticle accumulation in flow using optimized microfluidic chambers. / Kusunose, J.; Gagnon, M. K J; Seo, Jai; Ferrara, K. W.

In: Journal of Drug Targeting, Vol. 22, No. 1, 01.2014, p. 48-56.

Research output: Contribution to journalArticle

Kusunose, J. ; Gagnon, M. K J ; Seo, Jai ; Ferrara, K. W. / Quantitation of nanoparticle accumulation in flow using optimized microfluidic chambers. In: Journal of Drug Targeting. 2014 ; Vol. 22, No. 1. pp. 48-56.
@article{cf3c3726e5c0487aaae44437b249674e,
title = "Quantitation of nanoparticle accumulation in flow using optimized microfluidic chambers",
abstract = "Background: The vascular cell adhesion molecule-1 (VCAM-1) targeting peptide sequence, VHPKQHR, is a promising moiety for targeting atherosclerosis through incorporation into nanoparticles such as dendrimers and liposomes. Purpose: We aim to develop VCAM-1-targeted nanoparticles that effectively accumulate on the endothelium under shear conditions and to develop robust microfluidic chambers able to house sufficient cells for flow cytometric measurements. Methods: Carboxyfluorescein-labeled monomeric VHP-peptide, tetrameric VHP-dendrimers (bisbidentate or radial architecture, with or without N-terminal acetylation) and VHP-peptide liposomes were prepared. Human umbilical vein endothelial cells were treated with nanoparticles under 0 or 2.9 dyne/cm2 shear, and particle binding was quantified. Flow chambers cured at various temperatures, with or without glass backings were fabricated, characterized for deformation and applied in experiments. Results: Although liposomes accumulated with highest efficiency, dendrimers also demonstrated specific binding. N-terminal acetylation significantly reduced dendrimer binding, and despite shorter movement range, bisbidentate dendrimers outperformed radial dendrimers, suggesting multiple epitope presence within its estimated arm-span of 57{\AA}. Under shear, while liposome binding increased 300{\%}, dendrimer binding to cells decreased 65{\%}. Through higher temperature curing and glass backing insertion, polydimethylsiloxane flow chambers maintaining rectangular cross-section with aspect-ratio as low as 1:111 were achieved. Conclusion: Optimized dendrimers and liposomal nanocarriers specifically accumulated onto cells within microfluidic chambers.",
keywords = "Atherosclerosis, Dendrimers, in vitro model, Liposomes, Peptide, Targeted drug delivery",
author = "J. Kusunose and Gagnon, {M. K J} and Jai Seo and Ferrara, {K. W.}",
year = "2014",
month = "1",
doi = "10.3109/1061186X.2013.837468",
language = "English (US)",
volume = "22",
pages = "48--56",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Quantitation of nanoparticle accumulation in flow using optimized microfluidic chambers

AU - Kusunose, J.

AU - Gagnon, M. K J

AU - Seo, Jai

AU - Ferrara, K. W.

PY - 2014/1

Y1 - 2014/1

N2 - Background: The vascular cell adhesion molecule-1 (VCAM-1) targeting peptide sequence, VHPKQHR, is a promising moiety for targeting atherosclerosis through incorporation into nanoparticles such as dendrimers and liposomes. Purpose: We aim to develop VCAM-1-targeted nanoparticles that effectively accumulate on the endothelium under shear conditions and to develop robust microfluidic chambers able to house sufficient cells for flow cytometric measurements. Methods: Carboxyfluorescein-labeled monomeric VHP-peptide, tetrameric VHP-dendrimers (bisbidentate or radial architecture, with or without N-terminal acetylation) and VHP-peptide liposomes were prepared. Human umbilical vein endothelial cells were treated with nanoparticles under 0 or 2.9 dyne/cm2 shear, and particle binding was quantified. Flow chambers cured at various temperatures, with or without glass backings were fabricated, characterized for deformation and applied in experiments. Results: Although liposomes accumulated with highest efficiency, dendrimers also demonstrated specific binding. N-terminal acetylation significantly reduced dendrimer binding, and despite shorter movement range, bisbidentate dendrimers outperformed radial dendrimers, suggesting multiple epitope presence within its estimated arm-span of 57Å. Under shear, while liposome binding increased 300%, dendrimer binding to cells decreased 65%. Through higher temperature curing and glass backing insertion, polydimethylsiloxane flow chambers maintaining rectangular cross-section with aspect-ratio as low as 1:111 were achieved. Conclusion: Optimized dendrimers and liposomal nanocarriers specifically accumulated onto cells within microfluidic chambers.

AB - Background: The vascular cell adhesion molecule-1 (VCAM-1) targeting peptide sequence, VHPKQHR, is a promising moiety for targeting atherosclerosis through incorporation into nanoparticles such as dendrimers and liposomes. Purpose: We aim to develop VCAM-1-targeted nanoparticles that effectively accumulate on the endothelium under shear conditions and to develop robust microfluidic chambers able to house sufficient cells for flow cytometric measurements. Methods: Carboxyfluorescein-labeled monomeric VHP-peptide, tetrameric VHP-dendrimers (bisbidentate or radial architecture, with or without N-terminal acetylation) and VHP-peptide liposomes were prepared. Human umbilical vein endothelial cells were treated with nanoparticles under 0 or 2.9 dyne/cm2 shear, and particle binding was quantified. Flow chambers cured at various temperatures, with or without glass backings were fabricated, characterized for deformation and applied in experiments. Results: Although liposomes accumulated with highest efficiency, dendrimers also demonstrated specific binding. N-terminal acetylation significantly reduced dendrimer binding, and despite shorter movement range, bisbidentate dendrimers outperformed radial dendrimers, suggesting multiple epitope presence within its estimated arm-span of 57Å. Under shear, while liposome binding increased 300%, dendrimer binding to cells decreased 65%. Through higher temperature curing and glass backing insertion, polydimethylsiloxane flow chambers maintaining rectangular cross-section with aspect-ratio as low as 1:111 were achieved. Conclusion: Optimized dendrimers and liposomal nanocarriers specifically accumulated onto cells within microfluidic chambers.

KW - Atherosclerosis

KW - Dendrimers

KW - in vitro model

KW - Liposomes

KW - Peptide

KW - Targeted drug delivery

UR - http://www.scopus.com/inward/record.url?scp=84890384293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890384293&partnerID=8YFLogxK

U2 - 10.3109/1061186X.2013.837468

DO - 10.3109/1061186X.2013.837468

M3 - Article

C2 - 24079404

AN - SCOPUS:84890384293

VL - 22

SP - 48

EP - 56

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 1

ER -